Detalles de la búsqueda
1.
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.
Breast Cancer Res Treat
; 187(1): 275-285, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392843
2.
Chemotherapy-induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design.
Cancer
; 126(20): 4602-4613, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780430
3.
Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors.
Cancer
; 120(3): 442-50, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24151111
4.
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.
Cancer
; 120(3): 425-32, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24436136
5.
The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.
Cancer
; 119(24): 4333-40, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24114037
6.
Evolution of Cancer Care Delivery Research in the NCI Community Oncology Research Program.
J Natl Cancer Inst
; 112(6): 557-561, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31845965
7.
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Cancer Med
; 9(6): 2146-2152, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32009305
8.
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
J Am Med Inform Assoc
; 26(4): 276-285, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30840079
9.
Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.
J Clin Oncol
; : JCO2018786624, 2018 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30240328
10.
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
JAMA Oncol
; 3(8): 1043-1050, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28208174
11.
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
Int J Radiat Oncol Biol Phys
; 98(2): 409-418, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463161
12.
Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.
J Clin Oncol
; 23(3): 591-8, 2005 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15659506
13.
Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
J Clin Oncol
; 23(27): 6682-9, 2005 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16170176
14.
Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
J Oncol Pract
; 12(4): e388-95, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27026648
15.
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
JAMA Oncol
; 1(8): 1051-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26270597
16.
Clinical research education: perspectives of nurses, employers, and educators.
J Nurs Educ
; 53(8): 466-72, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25050563
17.
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.
J Natl Cancer Inst
; 106(7)2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25006191
18.
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
J Natl Cancer Inst
; 106(9)2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25265940
19.
Health related quality of life in NCI-sponsored cancer treatment trials.
Semin Oncol Nurs
; 26(1): 68-78, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20152580
20.
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.
J Pain Symptom Manage
; 39(6): 1086-99, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20538190